Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Aug;80(8):728–731. doi: 10.1136/bjo.80.8.728

Retinopathy of prematurity in infants of birth weight > 2000 g after haemorrhagic shock at birth.

C Jandeck 1, U Kellner 1, H Kössel 1, M Bartsch 1, H T Versmold 1, M H Foerster 1
PMCID: PMC505590  PMID: 8949718

Abstract

BACKGROUND: The risk of retinopathy of prematurity (ROP) is associated with low birth weight and low gestational age. For ROP screening examination is recommended in infants weighing < or = 1500 g or of less than 32 weeks' gestational age. METHODS: From 1991 ROP screening was performed in 452 premature infants with either a birth weight < or = 1500 g (n = 303) or a birth weight > 1500 g (n = 149) and who required additional oxygen supplementation or underwent surgery with general anaesthesia before estimated term. RESULTS: Unexpectedly, three infants with birth weights between 2080 and 2325 g and a gestational age of 32 or 33 weeks developed stage 2 or 3 ROP. One of these underwent cryocoagulation. In three infants, preterm birth was induced by sudden placental abruption with severe prenatal blood loss followed by haemorrhagic shock. The umbilical cord packed cell volume was reduced to 0.14-0.19 (normal 0.43-0.63). All three infants underwent surgery with general anaesthesia within the first weeks of life. Of the remaining 449 infants none with a birth weight > 1650 g developed any stage of ROP. CONCLUSION: Severe prenatal blood loss requiring blood transfusions and surgery with general anaesthesia may induce higher stages of ROP even in infants with birth weights exceeding the usual screening criteria.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger W., Meindl A., van de Pol T. J., Cremers F. P., Ropers H. H., Döerner C., Monaco A., Bergen A. A., Lebo R., Warburg M. Isolation of a candidate gene for Norrie disease by positional cloning. Nat Genet. 1992 Jun;1(3):199–203. doi: 10.1038/ng0692-199. [DOI] [PubMed] [Google Scholar]
  2. Brockhurst R. J., Chishti M. I. Cicatricial retrolental fibroplasia: its occurrence without oxygen administration and in full term infants. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975;195(2):113–128. doi: 10.1007/BF00417114. [DOI] [PubMed] [Google Scholar]
  3. Chen Z. Y., Battinelli E. M., Fielder A., Bundey S., Sims K., Breakefield X. O., Craig I. W. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet. 1993 Oct;5(2):180–183. doi: 10.1038/ng1093-180. [DOI] [PubMed] [Google Scholar]
  4. Chen Z. Y., Battinelli E. M., Woodruff G., Young I., Breakefield X. O., Craig I. W. Characterization of a mutation within the NDP gene in a family with a manifesting female carrier. Hum Mol Genet. 1993 Oct;2(10):1727–1729. doi: 10.1093/hmg/2.10.1727. [DOI] [PubMed] [Google Scholar]
  5. Cooke R. W., Clark D., Hickey-Dwyer M., Weindling A. M. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr. 1993 Oct;152(10):833–836. doi: 10.1007/BF02073381. [DOI] [PubMed] [Google Scholar]
  6. Criswick V. G., Schepens C. L. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969 Oct;68(4):578–594. doi: 10.1016/0002-9394(69)91237-9. [DOI] [PubMed] [Google Scholar]
  7. Fielder A. R., Levene M. I. Screening for retinopathy of prematurity. Arch Dis Child. 1992 Jul;67(7 Spec No):860–867. doi: 10.1136/adc.67.7_spec_no.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fielder A. R., Shaw D. E., Robinson J., Ng Y. K. Natural history of retinopathy of prematurity: a prospective study. Eye (Lond) 1992;6(Pt 3):233–242. doi: 10.1038/eye.1992.46. [DOI] [PubMed] [Google Scholar]
  9. Flynn J. T. Retinopathy of prematurity. Pediatr Clin North Am. 1987 Dec;34(6):1487–1516. doi: 10.1016/s0031-3955(16)36370-2. [DOI] [PubMed] [Google Scholar]
  10. Fuchs S., Kellner U., Wedemann H., Gal A. Missense mutation (Arg121Trp) in the Norrie disease gene associated with x-linked exudative vitreoretinopathy. Hum Mutat. 1995;6(3):257–259. doi: 10.1002/humu.1380060312. [DOI] [PubMed] [Google Scholar]
  11. Goggin M., O'Keefe M. Diode laser for retinopathy of prematurity--early outcome. Br J Ophthalmol. 1993 Sep;77(9):559–562. doi: 10.1136/bjo.77.9.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hammer M. E., Mullen P. W., Ferguson J. G., Pai S., Cosby C., Jackson K. L. Logistic analysis of risk factors in acute retinopathy of prematurity. Am J Ophthalmol. 1986 Jul 15;102(1):1–6. doi: 10.1016/0002-9394(86)90200-x. [DOI] [PubMed] [Google Scholar]
  13. Hindle N. W. Cryotherapy for retinopathy of prematurity: timing of intervention. Br J Ophthalmol. 1986 Apr;70(4):269–276. doi: 10.1136/bjo.70.4.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hittner H. M. Retinal and central nervous system abnormalities: syndromes which resemble retrolental fibroplasia. Metab Pediatr Syst Ophthalmol (1985) 1985;8(2-3):5–10. [PubMed] [Google Scholar]
  15. Holmström G., el Azazi M., Jacobson L., Lennerstrand G. A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden. Br J Ophthalmol. 1993 Jul;77(7):417–423. doi: 10.1136/bjo.77.7.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jandeck C., Kellner U., Helbig H., Versmold H., Foerster M. H. Natural course of retinal development in preterm infants without threshold retinopathy. Ger J Ophthalmol. 1995 May;4(3):131–136. [PubMed] [Google Scholar]
  17. Kellner U., Jandeck C., Helbig H., Versmold H., Bossi E., Körner F., Foerster M. H. Uberprüfung publizierter Empfehlungen für Screening-Untersuchungen bei Retinopathia praematurorum. Ophthalmologe. 1995 Oct;92(5):681–684. [PubMed] [Google Scholar]
  18. Kraushar M. F., Harper R. G., Sia C. G. Rentrolental fibroplasia in a full-term infant. Am J Ophthalmol. 1975 Jul;80(1):106–108. doi: 10.1016/0002-9394(75)90879-x. [DOI] [PubMed] [Google Scholar]
  19. Kushner B. J., Gloeckner E. Retrolental fibroplasia in full-term infants without exposure to supplemental oxygen. Am J Ophthalmol. 1984 Feb;97(2):148–153. doi: 10.1016/s0002-9394(14)76084-2. [DOI] [PubMed] [Google Scholar]
  20. Landers M. B., 3rd, Toth C. A., Semple H. C., Morse L. S. Treatment of retinopathy of prematurity with argon laser photocoagulation. Arch Ophthalmol. 1992 Jan;110(1):44–47. doi: 10.1001/archopht.1992.01080130046024. [DOI] [PubMed] [Google Scholar]
  21. Li Y., Müller B., Fuhrmann C., van Nouhuys C. E., Laqua H., Humphries P., Schwinger E., Gal A. The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533. Am J Hum Genet. 1992 Oct;51(4):749–754. [PMC free article] [PubMed] [Google Scholar]
  22. McNamara J. A., Tasman W., Brown G. C., Federman J. L. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology. 1991 May;98(5):576–580. doi: 10.1016/s0161-6420(91)32247-4. [DOI] [PubMed] [Google Scholar]
  23. Ng Y. K., Fielder A. R., Shaw D. E., Levene M. I. Epidemiology of retinopathy of prematurity. Lancet. 1988 Nov 26;2(8622):1235–1238. doi: 10.1016/s0140-6736(88)90820-3. [DOI] [PubMed] [Google Scholar]
  24. Palmer E. A., Flynn J. T., Hardy R. J., Phelps D. L., Phillips C. L., Schaffer D. B., Tung B. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991 Nov;98(11):1628–1640. doi: 10.1016/s0161-6420(91)32074-8. [DOI] [PubMed] [Google Scholar]
  25. Penn J. S., Tolman B. L., Lowery L. A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci. 1993 Mar;34(3):576–585. [PubMed] [Google Scholar]
  26. Plager D. A., Orgel I. K., Ellis F. D., Hartzer M., Trese M. T., Shastry B. S. X-linked recessive familial exudative vitreoretinopathy. Am J Ophthalmol. 1992 Aug 15;114(2):145–148. doi: 10.1016/s0002-9394(14)73977-7. [DOI] [PubMed] [Google Scholar]
  27. Quinn G. E., Johnson L., Abbasi S. Onset of retinopathy of prematurity as related to postnatal and postconceptional age. Br J Ophthalmol. 1992 May;76(5):284–288. doi: 10.1136/bjo.76.5.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ravia Y., Braier-Goldstein O., Bat-Miriam K. M., Erlich S., Barkai G., Goldman B. X-linked recessive primary retinal dysplasia is linked to the Norrie disease locus. Hum Mol Genet. 1993 Aug;2(8):1295–1297. doi: 10.1093/hmg/2.8.1295. [DOI] [PubMed] [Google Scholar]
  29. Saito Y., Omoto T., Cho Y., Hatsukawa Y., Fujimura M., Takeuchi T. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefes Arch Clin Exp Ophthalmol. 1993 Mar;231(3):151–156. doi: 10.1007/BF00920938. [DOI] [PubMed] [Google Scholar]
  30. Schaffer D. B., Palmer E. A., Plotsky D. F., Metz H. S., Flynn J. T., Tung B., Hardy R. J. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993 Feb;100(2):230–237. doi: 10.1016/s0161-6420(93)31665-9. [DOI] [PubMed] [Google Scholar]
  31. Schulman J., Jampol L. M., Schwartz H. Peripheral proliferative retinopathy without oxygen therapy in a full-term infant. Am J Ophthalmol. 1980 Oct;90(4):509–514. doi: 10.1016/s0002-9394(14)75020-2. [DOI] [PubMed] [Google Scholar]
  32. Stefani F. H., Ehalt H. Non-oxygen induced retinitis proliferans and retinal detachment in full-term infants. Br J Ophthalmol. 1974 May;58(5):490–513. doi: 10.1136/bjo.58.5.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sullivan J. L. Retinopathy of prematurity. Low iron binding capacity may contribute. BMJ. 1993 Nov 20;307(6915):1353–1354. doi: 10.1136/bmj.307.6915.1353-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Warburg M. Norrie's disease. A congenital progressive oculo-acoustico-cerebral degeneration. Acta Ophthalmol (Copenh) 1966;(Suppl):1–47. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES